The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Celanese Corp

NYSE: CE
Last

(U.S.) $70.49

Today's change-0.49 -0.69%
Updated May 4 4:04 PM EDT. Delayed by at least 15 minutes.
 

Celanese Corp

NYSE: CE
Last

(U.S.) $70.49

Today's change-0.49 -0.69%
Updated May 4 4:04 PM EDT. Delayed by at least 15 minutes.

Celanese Corp down (U.S.)$0.49

Celanese Corp closed lower Wednesday, dropping (U.S.)$0.49 or 0.69% to (U.S.)$70.49. Shares have lost 1.41% over the last five days, but have gained 4.69% over the last year to date. This security has outperformed the S&P 500 by 8.27% during the last year.

Key company metrics

  • Open(U.S.) $70.52
  • Previous close(U.S.) $70.98
  • High(U.S.) $71.36
  • Low(U.S.) $70.20
  • Bid / Ask-- / --
  • YTD % change+4.69%
  • Volume573,411
  • Average volume (10-day)947,059
  • Average volume (1-month)932,338
  • Average volume (3-month)974,916
  • 52-week range(U.S.) $54.35 to (U.S.) $74.55
  • Beta1.84
  • Trailing P/E33.41×
  • P/E 1 year forward10.77×
  • Forward PEG1.05×
  • Indicated annual dividend(U.S.) $1.44
  • Dividend yield2.04%
  • Trailing EPS(U.S.) $2.11
Updated May 4 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.53%

Based on its net profit margin of 5.53%, Celanese Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.55%Sector:Basic MaterialsIndustry:Chemicals - Commodity

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1,4041,3341,4131,477
Total other revenue--------
Total revenue1,4041,3341,4131,477
Gross profit390259303375
Total cost of revenue1,0141,0751,1101,102
Total operating expense1,1171,6391,2271,289
Selling / general / administrative8020993106
Research & development19211959
Depreciation / amortization2233
Interest expense (income), net operating--------
Unusual expense (income)5159516
Other operating expenses, total--174--0
Operating income287-305186188
Interest income (expense), net non-operating-35-33-29-30
Gain (loss) on sale of assets--------
Other--------
Income before tax318-270225227
Income after tax258-301151203
Income tax, total60317424
Net income257-298161205
Total adjustments to net income--------
Net income before extra. items256-298161207
Minority interest-23104
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items256-298161207
Inc. avail. to common incl. extra. items257-298161205
Diluted net income257-298161205
Dilution adjustment--------
Diluted weighted average shares148147151154
Diluted EPS excluding extraordinary itemsvalue per share1.73-2.031.071.34
Dividends per sharevalue per share0.300.300.300.30
Diluted normalized EPSvalue per share1.76-1.331.091.44